Document is current

Article History

Received: 16 December 2025

Accepted: 8 February 2026

First Online: 16 March 2026

Declarations

:

: This retrospective international survey study analyzed anonymized questionnaire responses from professionals involved in lung cancer screening and did not involve patient interventions or direct patient data collection. Under institutional and national regulations, this type of research does not require formal IRB/ethics committee approval, and written informed consent is not required. Therefore, ethics approval and consent to participate are not applicable.

: Not applicable, as no individual person’s data in identifiable form are presented.

: M.F.G.K. received research support from Philips Healthcare. A.v.d.L. receives research funding from Penumbra, Boehringer, Medtronic, Stryker, Thrombolytic Science, GE HealthCare, Siemens Healthineers, Philips Healthcare, all paid to the institution. H.U.K. received research grants from Siemens, Philips, and Boehringer Ingelheim. H.U.K. was a speaker of Honoraria at Siemens, Philips, Boehringer Ingelheim, and is a scientific advisor to Median and contextflow. H.P. received research support from Boehringer Ingelheim, AstraZeneca, Siemens Healthineers and the Christian Doppler Research Association, EU Commission (EU4Health, Horizon Europe Health). H.P. was a speaker of Honoraria at AstraZeneca, BMS, Boehringer Ingelheim, Bracco, Daiichi Sankyo, Janssen, MSD, Novartis, Roche, Sanofi, Siemens Healthineers, Takeda. H.P. is a member of the Scientific Editorial Board of Insights into Imaging and, as such, did not participate in the selection or review processes for this article. The remaining authors declare no conflicts of interest.